Egyptian B2B e-health startup 30Med has raised an undisclosed amount of pre-seed funding from angel investors to further develop its platform and expand its reach.
Founded in 2023 by Ayman Ragab, 30Med aims to bridge the gap between pharmaceutical companies and physicians by providing interactive videos and conference events that showcase new medicines and facilitate ongoing learning.
The pre-seed round of funding will provide the company with the necessary resources to further develop its platform and expand its reach within the medical community.
“We are thrilled to announce the successful completion of our pre-seed funding round,” Ragab. “This milestone not only validates the importance of our mission but also enables us to accelerate our efforts in transforming medical education.”
In addition to securing funding, 30Med has already achieved remarkable traction within the medical community. The platform boasts a substantial user base, comprising doctors who are eager to stay informed and engaged with the latest advancements in medicine and pharmaceuticals.
